🧠 Ask this record

Get an AI answer drawn only from the NIH Pandemic-Era Grants documents indexed here — every claim cited back to the filing or proceeding it came from. It will tell you plainly when the record doesn't cover your question, rather than guessing.

9873 documents

10k: A platform for immersive science education

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

Laura Lynn Gonzalez · DYNAMOID, INC. · 2024 · $1,036,415 — Across the country, students are unengaged and unmotivated in science classes, resulting in lowered self-efficacy and decreased interest in further STEM classes or STEM careers. For schools, falling test scores and fewer STEM courses offered affect rankings and the ability to attract students and st…

Washington University Rheumatic Diseases Research Resource-based Center

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

Deborah J Lenschow · WASHINGTON UNIVERSITY · 2024 · $777,498 — OVERALL ABSTRACT The WU-RDRRC seeks to advance the health of patients with rheumatic diseases by supporting enabling technology and promoting the members’ basic, clinical, and translational research interests that are organized around three major themes: 1) elucidating basic mechanisms of inflammat…

Development of a Blood-based Test for Identifying Synucleinopathy in Patients with Dementia

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

Erez Eitan · NEURODEX INC · 2024 · $942,163 — PROJECT SUMMARY In this Fast Track SBIR application, NeuroDex, Inc. proposes to use its expertise in extracellular vesicle (EV) immunoaffinity isolation to develop a blood test that detects synucleinopathies with high sensitivity, with the long- term goal of helping clinicians identify patients for …

Clinical and mechanistic studies defining optimal preparative approaches to infants with IL2RG/JAK3/RAG1/RAG2 SCID: a randomized trial of busulfan dosage

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

JEFFERY J AULETTA · NATIONAL MARROW DONOR PROGRAM · 2024 · $1,072,951 — Project Summary Severe combined immunodeficiency (SCID) is a group of genetic disorders that abrogate T cell development and function. Allogeneic hematopoietic cell transplantation (HCT) is the standard treatment for the disease and can be performed successfully in SCID patients without the high do…

IP21-002, Surveillance for Vaccine Preventable Disease in Children

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

Julie Anne Boom · BAYLOR COLLEGE OF MEDICINE · 2024 · $1,234,285 — Component A: Project Summary Texas Children’s Hospital (TCH) aims to continue inpatient and emergency department surveillance as part of the larger national New Vaccine Surveillance Network (NVSN) to assess the burden of pediatric respiratory and gastrointestinal illnesses and acute flaccid myelitis…

A clinical trial to evaluate the impact of broadly neutralizing antibody VRC01 on HIV viral reservoir and maintenance of suppression in a cohort of early-treated children in Botswana

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

Daniel R. Kuritzkes · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · 2024 · $301,913 — The Dual bNAb Treatment in Children Study (“Tatelo”) is an ongoing phase I/II, multi-site clinical trial of dual treatment with two broadly neutralizing monoclonal antibodies (bNAbs), VRC01LS and 10-1074, offered to HIV-1 infected virally suppressed children. The study is evaluating the efficacy o…

Arterivirus receptors: rules of engagement for cross-species infection

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

Adam Lee Bailey · UNIVERSITY OF WISCONSIN-MADISON · 2024 · $243,505 — PROJECT SUMMARY/ABSTRACT As COVID-19 has illustrated, the emergence of novel RNA viruses from wild animals poses a significant threat to human health. In this proposal, we will begin to assess the zoonotic potential of an entire family of viruses: the arteriviruses. The arteriviruses are the only ma…

Prenatal Social Connection and Disruption During the COVID-19 Pandemic: Effects on Maternal and Infant Health

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

Darby E. Saxbe · UNIVERSITY OF SOUTHERN CALIFORNIA · 2024 · $353,073 — PROJECT SUMMARY The COVID-19 pandemic has had sweeping effects on pregnant women and their partners. The need to adhere to social distancing guidelines has altered the social connectedness of expectant parents, with effects on stress, loneliness, reduced access to in- person prenatal care, and chil…

Mechanisms of anosmia and brain infection in a genetic mouse model of COVID-19

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

Sarah E. Millar · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · 2024 · $731,611 — Project Summary/Abstract Infection of the olfactory epithelium in COVID-19 patients is thought to underlie loss of smell (anosmia), a pathognomonic symptom that can be long-term in some patients, significantly affecting quality of life. The olfactory epithelium is also believed to be a major entry p…

Develop a novel red blood cell-based microfluidic approach to assess and diagnose ME/CFS

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

Jiandi Wan · UNIVERSITY OF CALIFORNIA AT DAVIS · 2024 · $224,955 — Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex, debilitating disease with inconclusive causes and no laboratory-based diagnostic tests. Oxygen tension (PO2)-regulated red blood cell (RBC) capillary velocity has emerged recently as a new mechanism regulating cerebral capilla…

Immune-mediated pathogenic mechanisms of Neuro-PASC in Veterans

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

JENNIFER M LOFTIS · PORTLAND VA MEDICAL CENTER · 2024 — Among the concerns of infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the development of neurological manifestations of post-acute sequelae of SARS-CoV-2 infection (PASC) or neuro- PASC. Research shows that neuropsychiatric impairments, including cognitive problems, depr…

Characteristics and Determinants of Post-COVID Neurocognitive Dysfunction

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

Roger Bedimo · VA NORTH TEXAS HEALTH CARE SYSTEM · 2024 — Neurologic symptoms are among the most common post-acute sequelae of COVID-19 (PASC). Recent studies show that there is a very high rate of neurocognitive changes among Veterans surviving acute COVID- 19 infection. The long-term neurocognitive changes of this infection could be even worse and remain…

Optimizing the Daily Care Interactions Between Direct Care Staff and Assisted Living Residents with Dementia

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

Anju Paudel · PENNSYLVANIA STATE UNIVERSITY, THE · 2024 · $230,194 — PROJECT SUMMARY About 25% of daily care interactions between staff and residents in long-term care including Assisted Living Facilities (ALFs) comprise of poor care interactions. Individuals with Alzheimer’s disease and related dementias (ADRD) are especially at risk for poor care interactions relat…

An inoculation theory-based messaging intervention addressing misinformation about HPV vaccine on social media: The Inoculate for HPV Vaccine randomized controlled trial

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

Melanie Lynn Kornides · UNIVERSITY OF PENNSYLVANIA · 2024 · $592,790 — Project Summary Background: Misinformation on social media, or the sharing of false or incomplete information without intent to cause harm, is contributing to vaccine hesitancy among parents and impeding uptake of the HPV vaccine among adolescents in the United States. Innovative communication strat…

Initiation of immune responses to SARS COV2 in the oral cavity and upper airway

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

GILL DIAMOND · TULANE UNIVERSITY OF LOUISIANA · 2024 · $737,561 — Abstract Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), a life-threatening illness with multi-system involvement in a subset of infected individuals. Oral and nasopharyngeal (NP) epithelial cells express the SARS-CoV-2 receptor…

U-RISE Training the Next Generation of Basic Biomedical Researchers A Holistic Approach

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

Cheryl Hogue · CALIFORNIA STATE UNIVERSITY NORTHRIDGE · 2024 · $655,597 — Project Summary/Abstract. We seek to establish the Undergraduate Research Initiative for Student Enhancement (U-RISE) program at California State University, Northridge (CSUN). We use a growth mindset as a scaffolding for the activities and interventions we propose in this new program. The future of…

PrEP Implementation Science with Hard to Reach Populations in India

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

Anne Elizabeth Fehrenbacher · UNIVERSITY OF SOUTHERN CALIFORNIA · 2024 · $182,088 — PROJECT SUMMARY/ABSTRACT Anne E. Fehrenbacher, PhD, MPH is a social epidemiologist in the Department of Psychiatry and Biobehavioral Sciences at the University of California, Los Angeles and a Fogary GloCal Fellow at the Public Health Research Institute of India. Dr. Fehrenbacher’s long-term career…

Targeting TB transmission hotspots to find undiagnosed TB in South Africa: a genomic, geospatial and modeling study (TARGET- TB)

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

Barun Mathema · COLUMBIA UNIVERSITY HEALTH SCIENCES · 2024 · $632,098 — Project Summary Despite renewed public health efforts, including more effective treatment, tuberculosis (TB) incidence has reduced only incrementally, an effect driven by the inability to contain community TB transmission. Early identification and treatment of infectious individuals is central to br…

High-throughput nanoIEA-based Assay for Screening Immune Cell-Vascular Interactions

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

Deok-Ho Kim · CORNELL UNIVERSITY · 2024 · $237,913 — PROJECT SUMMARY Blood vessels play a central role in maintaining host immunity by transporting immune cells to sites of infection. During the process, blood vessels experience endothelial junction remodeling to control vascular permeability and immune cell extravasation. Under infection, blood vesse…

2/2 REPRIEVE Extension for Trial Completion

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

Michael Tse-Yin Lu · MASSACHUSETTS GENERAL HOSPITAL · 2024 · $1,195,255 — Project Summary/Abstract This proposal will support the Data Coordinating Center (DCC) for the Randomized Trial to Prevent Vascular Events in HIV Trial (REPRIEVE) Extension for up to two additional years, with an additional year for study close-out. This additional time is necessary to collect the m…